Ethan Basch, MD

Ethan Basch, MD

Office Phone

646-888-8332

Current Research Interests

Dr. Basch is a practicing medical oncologist and health services researcher whose work focuses on the use of patient-reported measures to assess drug toxicity and symptom endpoints in clinical research, routine care, and quality assessment.  His group established that the current approach to adverse event reporting in oncology misses essential information about the patient experience, which can be captured via direct patient reporting.  His work has been published in the New England Journal of Medicine, JAMA, the Lancet, Lancet Oncology, Journal of Clinical Oncology, Journal of the National Cancer Institute, and Journal of the American Medical Informatics Association.  He leads the National Cancer Institute’s initiative to create a patient version of the standard lexicon for adverse event reporting in oncology trials, the Common Terminology Criteria for Adverse Events (PRO-CTCAE).  He is a member of the Board of Scientific Advisors of the National Cancer Institute, a member of the Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI), Co-Chair of the Health Outcomes Committee for the Alliance cooperative group, Board Member of the International Society for Quality of Life Research (ISOQOL), and has led multiple guideline panels for the American Society of Clinical Oncology (ASCO). His research is funded by grants and contracts from the NCI, Department of Defense, ASCO, and multiple foundations.  He is currently a faculty member at Memorial Sloan Kettering Cancer Center with ongoing research based at MSKCC, but spends most of his time at the University of North Carolina at Chapel Hill, where he is Director of the Cancer Outcomes Research Program.  Dr. Basch’s clinical focus is prostate cancer.

Education

Harvard Medical School

Publications

Basch E, Aronson N, Berg A, Flum D, Gabriel S, Goodman SN, Helfand M, Ioannidis JP, Lauer M, Meltzer D, Mittman B, Newhouse R, Normand SL, Schneeweiss S, Slutsky J, Tinetti M, Yancy C (Methodology Committee of the Patient-Centered Outcomes Research Institute [PCORI]). Methodological Standards and Patient-Centeredness in Comparative Effectiveness Research: the PCORI Perspective. JAMA 2012;307(15):1636-40. [PubMed Abstract] 

Basch E, Oliver TK, Vickers A, Thompson I, Kantoff P, Howard Parnes, Loblaw A, Roth B, Williams J, Nam RK. Screening for Prostate Cancer with Prostate-Specific Antigen (PSA) Testing: American Society of Clinical Oncology Recommendations. J Clin Oncol 2012;30(24):3020-3025. [PubMed Abstract]

Basch E. Beyond the FDA PRO Guidance: Steps toward integrating meaningful patient-reported outcomes into regulatory trials and US drug labels. Value Health 2012;15:401 403. [PubMed Abstract]

Basch E, Abernethy AP, Mullins CD, Reeve BB, Smith ML, Coons SJ, Sloan J, Wenzel K, Chauhan C, Eppard W, Frank ES, Lipscomb J, Raymond SA, Spencer M, Tunis S. Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative-Effectiveness Research in Adult Oncology. J Clin Oncol 2012; Oct 15 [Epub ahead of print]. [PubMed Abstract]

Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med 2010;362(10):865-9. [PubMed Abstract]

Read more

  1. [PubMed Abstract]

    Basch E, Aronson N, Berg A, Flum D, Gabriel S, Goodman SN, Helfand M, Ioannidis JP, Lauer M, Meltzer D, Mittman B, Newhouse R, Normand SL, Schneeweiss S, Slutsky J, Tinetti M, Yancy C (Methodology Committee of the Patient-Centered Outcomes Research Institute [PCORI]). Methodological Standards and Patient-Centeredness in Comparative Effectiveness Research: the PCORI Perspective. JAMA 2012;307(15):1636-40.

  2. [PubMed Abstract]

    Basch E , Oliver TK, Vickers A, Thompson I, Kantoff P, Howard Parnes, Loblaw A, Roth B, Williams J, Nam RK. Screening for Prostate Cancer with Prostate-Specific Antigen (PSA) Testing: American Society of Clinical Oncology Recommendations (Provisional Clinical Opinion). J Clin Oncol 2012;30(24):3020-3025.

  3. [PubMed Abstract]

    Basch E . Beyond the FDA PRO Guidance: Steps toward integrating meaningful patient- reported outcomes into regulatory trials and US drug labels. Value Health 2012;15:401 403.

  4. [PubMed Abstract]

    Logothetis CJ, Basch E , Molina A, Fizazi K, North SA, Chi KN, Jones RJ, Goodman OB, Mainwaring PN, Sternberg CN, Efstathiou E, Gagnon DD, Rothman M, Hao Y, Liu CS, Kheoh TS, Haqq CM, Scher HI, de Bono JS. Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial. Lancet Oncol 2012 Dec;13(12):1210-7.

  5. [PubMed Abstract]

    Basch E , Abernethy AP, Mullins CD, Reeve BB, Smith ML, Coons SJ, Sloan J, Wenzel K, Chauhan C, Eppard W, Frank ES, Lipscomb J, Raymond SA, Spencer M, Tunis S. Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative- Effectiveness Research in Adult Oncology. J Clin Oncol 2012; Oct 15 [Epub ahead of print].

  6. [PubMed Abstract]

    Loblaw DA, Prestrud AA, Somerfield MR, Oliver TK, Brouwers MC, Nam RK, Lyman GH, Basch E . American Society of Clinical Oncology Clinical Practice Guidelines: Formal Systematic Review-Based Consensus Methodology. J Clin Oncol 2012; Jul 9 [Epub ahead of print]. 

  7. [PubMed Abstract]

    Bennett AV, Jensen RE, Basch E . Electronic patient-reported outcome systems in oncology clinical practice. CA Cancer J Clin 2012;62(5):336-47.

  8. Ryan CJ, Smith MR, de Bono JS, Molina A, Logothetis CJ, de Souza P, Fizazi K, Mainwaring P, Piulats JM, Ng S, Carles J, Mulders PFA, Basch E , Small EJ, Saad F, Schrijvers D, Poppel HV, Mukherjee SD, Suttmann H, Gerritsen WR, Flaig TW, George DJ, Yu EY, Efstathiou E, Pantuck A, Winquist E, Higano CS, Park Y, Kheoh T, Griffin T, Scher HI, Rathkopf DE. Randomized Phase 3 Trial of Abiraterone Acetate in Men with Metastatic Castration-Resistant Prostate Cancer and No Prior Chemotherapy. New Engl J Med 2012, in press.

  9. [PubMed Abstract]

    Atkinson TM, Halabi S, Bennett AV, Rogak L, Sit L, Li Y, Kaplan E, Basch E (Cancer and Leukemia Group B). Measurement of Affective and Activity Pain Interference Using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903. Pain Med 2012; Oct 30 [Epub ahead of print].

  10. [PubMed Abstract]

    Damast S, Alektiar KM, Goldfarb S, Eaton A, Patil S, Mosenkis J, Bennett A, Atkinson T, Jewell E, Leitao M, Barakat R, Carter J, Basch E . Sexual Functioning Among Endometrial Cancer Patients Treated With Adjuvant High-Dose-Rate Intra-Vaginal Radiation Therapy. Int J Radiat Oncol Biol Phys 2012;84(2):e187-93. 

  11. [PubMed Abstract]

    Atkinson TM, Li Y, Coffey CW, Sit L, Shaw M, Lavene D, Bennett AV, Fruscione M, Rogak L, Hay J, Gönen M, Schrag D, Basch E . Reliability of adverse symptom event reporting by clinicians. Qual Life Res 2012;21:1159-1164.

  12. [PubMed Abstract]

    Ahmed S, Berzon RA, Revicki DA, Lenderking WR, Moinpour CM, Basch E , Reeve BB, Wu AW; on behalf of the International Society for Quality of Life Research. The Use of Patient- reported Outcomes (PRO) Within Comparative Effectiveness Research: Implications for Clinical Practice and Health Care Policy. Med Care 2012; Aug 23 [Epub ahead of print].

  13. [PubMed Abstract]

    Andikyan V, Rezk Y, Einstein MH, Gualtiere G, Leitao MM Jr, Sonoda Y, Abu-Rustum NR, Barakat RR, Basch EM , Chi DS. A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery. Gynecol Oncol 2012;127(2):273-7.

  14. [PubMed Abstract]

    Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM , Ferrell BR, Loscalzo M, Meier DE, Paice JA, Peppercorn JM, Somerfield M, Stovall E, Von Roenn JH. American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care into Standard Oncology Care. J Clin Oncol 2012;30(8):880-7.

  15. [PubMed Abstract]

    Andikyan V, Rezk Y, Einstein MH, Gualtiere G, Leitao MM Jr, Sonoda Y, Abu-Rustum NR, Barakat RR, Basch EM , Chi DS. A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery. Gynecol Oncol. 2012; Aug 4 [Epub ahead of print].

  16. [PubMed Abstract]

    Blinder VS, Patil S, Thind A, Diamant A, Hudis CA, Basch E , Maly RC. Return to work in low-income Latina and non-Latina white breast cancer survivors: A 3-year longitudinal study. Cancer 2012;118(6):1664-74.

  17. [PubMed Abstract]

    Vickers AJ, Sjoberg D, Basch E , Sculli F, Shouery M, Laudone V, Touijer K, Eastham J, Scardino PT. How Do You Know If You Are Any Good? A Surgeon Performance Feedback System for the Outcomes of Radical Prostatectomy. Eur Urol 2012;61(2):284-9.

  18. [PubMed Abstract]

    Romanus D, Kindler HL, Archer L, Basch E , Niedzwiecki D, Weeks J, Schrag D; Cancer and Leukemia Group B. Does Health-Related Quality of Life Improve for Advanced Pancreatic Cancer Patients Who Respond to Gemcitabine? Analysis of a Randomized Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303). J Pain Symptom Manage 2012;43(2):205:17.

  19. [PubMed Abstract]

    Basch E , Abernethy AP, Reeve BB. Assuring the patient centeredness of patient-reported outcomes: content validity in medical product development and comparative effectiveness research. Value Health 2011;14(8):965-6.

  20. [PubMed Abstract]

    Basch E , Bennett A, Pietanza MC. Use of patient-reported outcomes to improve the predictive accuracy of clinician-reported adverse events. J Natl Cancer Inst2011;103(24):1808-10.

  21. [PubMed Abstract]

    Swartz RJ, Schwartz C, Basch E , Cai L, Fairclough DL, McLeod L, Mendoza TR, Rapkin B; SAMSI Psychometric Program Longitudinal Assessment of Patient-Reported Outcomes Working Group. The king’s foot of patient-reported outcomes: current practices and new developments for the measurement of change. Qual Life Res 2011;20(8):1159-67.

  22. [PubMed Abstract]

    Basch E , Hesketh PJ, Kris MG, Prestrud AA, Temin S, Lyman GH. Antiemetics: AmericanSociety of Clinical Oncology Clinical Practice Guideline Update. J Oncol Pract2011;7(6):395-8.

  23. [PubMed Abstract]

    Basch E , Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark- Snow RA, Flaherty AM, Freundlich B, Morrow G, Rao KV, Schwartz RN, Lyman GH. American Society of Clinical Oncology Clinical Practice Guideline Update on Antiemetics. J Clin Oncol 2011;29(31):4189-98.

  24. [PubMed Abstract]

    Basch E , Somerfield M, Partridge A, Schnipper L, Lyman GH. Should cost and comparative value of treatments be considered in clinical practice guidelines? J Oncol Pract2011;7(6):398-401.

  25. [PubMed Abstract]

    Scher H, Morris MJ, Basch E , Heller G. Endpoints and outcomes in castration-resistant prostate cancer: from clinical trials to clinical practice. J Clin Oncol 2011;29(27):3695-704.

  26. [PubMed Abstract]

    Abernethy AP, Basch E . Clinical cancer informatics: creating pathways for personalized medicine and rapid learning cancer care. Cancer J 2011;17(4):195-6.

  27. [PubMed Abstract]

    Basch E , Reeve BB, Mitchell SA, Clauser SB, Minasian L, Sit L, Chilukuri R, Baumgartner P, Rogak L, Blauel E, Abernethy AP, Bruner D. Electronic toxicity monitoring and patient- reported outcomes. Cancer J 2011;17(4):231-4.

  28. [PubMed Abstract]

    Dworkin RH, Turk DC, Basch E , Berger A, Cleeland C, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Markman J, Porter L, Raja SN, Ross E, Todd K, Wallace M, Woolf CJ. Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy. Pain 2011;152(8):1705-8.

  29. [PubMed Abstract]

    Basch E , Abernethy AP. Supporting Clinical Practice Decisions with Real-Time Patient- Reported Outcomes. J Clin Oncol 2011;29(8):954-6.

  30. [PubMed Abstract]

    Movsas B, Vikram B, Hauer-Jensen M, Moulder J, Basch E , Brown SL, Kachnic LA, Dicker A, Coleman CN, Okunieff P. Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators. Clin Cancer Res 2011;17(2):222-8.

  31. [PubMed Abstract]

    Basch E , Abernethy A. Encouraging Clinicians to Incorporate Longitudinal Patient-Reported Symptoms in Routine Clinical Practice. J Oncol Pract 2011;7(1):23-5.

  32. Bruner DW, Hanisch LJ, Trotti A, Reeve BB, Schrag D, Sit L, Minasian L, O’Mara A, Denicoff A, Rowland J, Montello M, Geoghegan C, Abernethy A, Clauser S, Castro K, Mitchell S, Burke L, Trentacosti AM, Basch E . Stakeholder Perspectives on Implementing the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Trans Behav Med 2011;1:110-122.

  33. [PubMed Abstract]

    Atkinson, TM, Rosenfeld, BD, Sit, L, Mendoza, TR, Fruscione, M, Lavene, D, Shaw, M, Li, Y, Hay, J, Cleeland, C, Scher, HI, Breitbart, WS, Basch, E. Using Confirmatory Factor Analysis to Evaluate Construct Validity of the Brief Pain Inventory. J Pain Symptom Manage 2011;41(3):558-65.

  34. [PubMed Abstract]

    Abernethy AP, Basch E , Bull J, Cleeland CS, Currow DC, Fairclough D, Hanson L, Hauser J, Ko D, Lloyd L, Morrison S, Otis-Green S, Pantilat S, Portenoy RK, Ritchie C, Rocker G, Wheeler JL, Zafar SY, Kutner JS. A strategy to advance the evidence base in Palliative Medicine: Formation of a palliative care research cooperative group. J Palliat Med 2010;13(12):1407-13.

  35. [PubMed Abstract]

    Atkinson TM, Mendoza TR, Sit L, Passik S, Scher HI, Cleeland C, Basch E . The Brief Pain Inventory and its “pain at its worst in the last 24 hours” item: clinical trial endpoint considerations. Pain Med 2010;11(3):337-46.

  36. [PubMed Abstract]

    Wang XS, Shi Q, Lu C, Basch E , Johnson VE, Mendoza TR, Mobley GM, Cleeland CS. Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer 2010;116(1):137-45.

  37. [PubMed Abstract]

    Jang TL, Bekelman JE, Liu Y, Bach PB, Basch E , Elkin EB, Zelefsky MJ, Scardino PT, Begg CB, Schrag D. Physician visits prior to treatment for clinically localized prostate cancer. Arch Intern Med 2010;170(5):440-50.

  38. [PubMed Abstract]

    Basch E . The missing voice of patients in drug-safety reporting. N Engl J Med 2010;362(10):865-9.

  39. [PubMed Abstract]

    Mularski RA, Campbell ML, Asch SM, Reeve BB, Basch E , Maxwell TL, Cuny J, Clauser SB, Snyder C, Seow H, Wu AW, Dy S. A review of quality of care evaluation for the palliation of dyspnea. Am J Respir Crit Care Med. 2010;181(6):534-8.

  40. [PubMed Abstract]

    Lacouture ME, Maitland ML, Segaert S, Setser A, Baran R, Fox LP, Epstein JB, Barasch A, Einhorn L, Wagner L, West DP, Rapoport BL, Kris MG, Basch E , Eaby B, Kurtin S, Olsen EA, Chen A, Dancey JE, Trotti A. A proposed EGFR inhibitor dermatologic adverse event- specific grading scale from the MASCC skin toxicity study group. Support Care Cancer 2010;18(4):509-22.

  41. [PubMed Abstract]

    Vickers AJ, Salz T, Basch E , Cooperberg MR, Carroll PR, Tighe F, Eastham J, Rosen RC. Electronic patient self-assessment and management (SAM): a novel framework for cancer survivorship. BMC Med Inform Decis Mak 2010;10:34.

  42. [PubMed Abstract]

    Vickers AJ, Savage CJ, Shouery M, Eastham JA, Scardino PT, Basch E . Validation study of a web-based assessment of functional recovery after radical prostatectomy. Health Qual Life Outcomes 2010;8:82-89.

  43. [PubMed Abstract]

    Gilligan TD, Seidenfeld J, Basch E , Einhorn LH, Smith DC, Stephenson AJ, Vaughn DJ, Cosby R, Hayes DF; American Society of Clinical Oncology. American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors. J Clin Oncol 2010;28(20):3388-404.

  44. [PubMed Abstract]

    Morris MJ, Basch E , Wilding G, Hussain M, Carducci MA, Higano C, Kantoff P, Oh WK, Small EJ, George D, Mathew P, Beer TM, Ryan C, Logothetis C, Scher HI. Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research. Clin Genitourin Cancer 2009;7(1):51-7.

  45. [PubMed Abstract]

    Basch E , Goldfarb S. Electronic patient-reported outcomes for collecting sensitive information from patients. J Support Oncol 2009;7(3):98-9.

  46. [PubMed Abstract]

    Basch E . Patient-reported outcomes in drug safety evaluation. Ann Oncol 2009;20(12):1905-6.

  47. [PubMed Abstract]

    Basch E , Jia X, Heller G, Barz A, Sit L, Fruscione M, Appawu M, Iasonos A, Atkinson T, Goldfarb S, Culkin A, Kris MG, Schrag D. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst 2009;101(23):1624-32.

  48. [PubMed Abstract]

    Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, Lenderking WR, Cella D, Basch E ; ISPOR ePRO Task Force. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health 2009;12(4):419-29.

  49. [PubMed Abstract]

    Ulbricht C, Basch E , Basch S, Bent S, Boon H, Burke D, Costa D, Falkson C, Giese N, Goble M, Hashmi S, Mukarjee S, Papaliodis G, Seamon E, Tanguay-Colucci S, Weissner W, Woods J. Systematic review of Bilberry (Vaccinium myrtillus). J Diet Suppl. 2009;6(2):162-200.

  50. [PubMed Abstract]

    Ulbricht C, Weissner W, Basch E , Giese N, Hammerness P, Rusie-Seamon E, Varghese M, Woods J. Maitake mushroom (Grifola frondosa): systematic review. J Soc Integr Oncol 2009;7(2):66-72.

  51. [PubMed Abstract]

    Scher HI, Halabi S, Tannock I, Morris M, Sternberg CN, Carducci MA, Eisenberger MA, Higano C, Bubley GJ, Dreicer R, Petrylak D, Kantoff P, Basch E , Kelly WK, Figg WD, Small EJ, Beer TM, Wilding G, Martin A, Hussain M; Prostate Cancer Clinical Trials Working Group. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol. 2008;26(7):1148-59.

  52. [PubMed Abstract]

    Vickers AJ, Basch E , Kattan MW. Against diagnosis. Ann Intern Med 2008;149(3):200-3.

  53. [PubMed Abstract]

    Basch E , Artz D, Iasonos A, Speakman J, Shannon K, Lin K, Pun C, Yong H, Fearn P, Barz A, Scher HI, McCabe M, Schrag D. Evaluation of an online platform for cancer patient self- reporting of chemotherapy toxicities. J Am Med Inform Assoc 2007;14(3):264-8.

  54. [PubMed Abstract]

    Basch E , Somerfield MR, Beer TM, Carducci MA, Higano CS, Hussain MH, Scher HI; American Society of Clinical Oncology. American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer. J Clin Oncol 2007;25(33):5313-8.

  55. [PubMed Abstract]

    Basch E , Iasonos A, Barz A, Culkin A, Kris MG, Artz D, Fearn P, Speakman J, Farquhar R, Scher HI, McCabe M, Schrag D. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol 2007;25(34):5374-80.

  56. [PubMed Abstract]

    Bekelman JE, Zelefsky MJ, Jang TL, Basch E , Schrag D. Variation in adherence to external beam radiotherapy quality measures among elderly men with localized prostate cancer. Int J Radiat Oncol Biol Phys 2007;69(5):1456-66.

  57. [PubMed Abstract]

    Motzer RJ, Basch E . Targeted drugs for metastatic renal cell carcinoma. Lancet 2007;370(9605):2071-3.

  58. [PubMed Abstract]

    Trotti A, Colevas AD, Setser A, Basch E . Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol 2007;25(32):5121-7.

  59. [PubMed Abstract]

    Ulbricht C, Armstrong J, Basch E , Basch S, Bent S, Dacey C, Dalton S, Foppa I, Giese N, Hammerness P, Kirkwood C, Sollars D, Tanguay-Colucci S, Weissner W. An evidence- based systematic review of Aloe vera by the natural standard research collaboration. J Herb Pharmacother. 2007;7(3-4):279-323.

  60. [PubMed Abstract]

    Ulbricht C, Basch E , Burke D, Cheung L, Ernst E, Giese N, Foppa I, Hammerness P, Hashmi S, Kuo G, Miranda M, Mukherjee S, Smith M, Sollars D, Tanguay-Colucci S, Vijayan N, Weissner W. Fenugreek (Trigonella foenum-graecum L. Leguminosae): systematic review. J Herb Pharmacother. 2007;7(3-4):143-77.

  61. [PubMed Abstract]

    Keifer D, Ulbricht C, Abrams TR, Basch E , Giese N, Giles M, DeFranco Kirkwood C, Miranda M, Woods J. Peppermint (Mentha piperita): systematic review. J Herb Pharmacother 2007;7(2):91-143.

  62. [PubMed Abstract]

    Basch E , Bent S, Collins J, Dacey C, Hammerness P, Harrison M, Smith M, Szapary P, Ulbricht C, Vora M, Weissner W. Flax and flaxseed oil (Linum usitatissimum): systematic review. J Soc Integr Oncol. 2007;5(3):92-105.

  63. [PubMed Abstract]

    Basch E . Expectations for specialized knowledge in oncology: time to reassess. Nat Clin Pract Oncol 2007;4(5):263.

  64. [PubMed Abstract]

    Ulbricht C, Basch E , Weissner W, Hackman D. An evidence-based systematic review of herb and supplement interactions. Expert Opin Drug Saf 2006;5(5):719-28.

  65. [PubMed Abstract]

    Basch E , Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, Scher HI, Schrag D. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events. Lancet Oncol 2006;7(11):903-9.

  66. [PubMed Abstract]

    Basch E , Bent S, Foppa I, Haskmi S, Kroll D, Mele M, Szapary P, Ulbricht C, Vora M, Yong S. Marigold (Calendula officinalis L.): systematic review. J Herb Pharmacother. 2006;6(3- 4):135-59.

  67. [PubMed Abstract]

    Brendler T, Gruenwald J, Ulbricht C, Basch E . Devil’s Claw (Harpagophytum procumbens DC): systematic review. J Herb Pharmacother. 2006;6(1):89-126.

  68. [PubMed Abstract]

    Basch E , Artz D, Dulko D, Scher K, Sabbatini P, Hensley M, Mitra N, Speakman J, McCabe M, Schrag D. Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol 2005;23(15):3552-61.

  69. [PubMed Abstract]

    Basch EM , Servoss JC, Tedrow UB. Safety assurances for dietary supplements policy issues and new research paradigms. J Herb Pharmacother 2005;5(1):3-15.

  70. [PubMed Abstract]

    Basch E , Thaler HT, Shi W, Yakren S, Schrag D. Use of information resources by patients with cancer and their companions. Cancer 2004;100(11):2476-83.

  71. [PubMed Abstract]

    Hammerness P, Basch E , Ulbricht C, Barrette EP, Foppa I, Basch S, Bent S, Boon H, Ernst E. St John’s wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist. Psychosomatics 2003;44(4):271-82.

  72. [PubMed Abstract]

    Basch E , Bonfiglio MF. Pharmaceutical manufacturer sponsorship and drug information. Arch Intern Med 2001;161(21):2625-6.

  73. [PubMed Abstract]

    Basch E , Cruz ME, Tapia D, Cruz A. Prevalence of epilepsy in a migrant population near Quito, Ecuador. Neuroepidemiology 1997;16(2):94-8.